vs
Side-by-side financial comparison of Atara Biotherapeutics, Inc. (ATRA) and Serve Robotics Inc. (SERV). Click either name above to swap in a different company.
Atara Biotherapeutics, Inc. is the larger business by last-quarter revenue ($1.6M vs $881.5K, roughly 1.8× Serve Robotics Inc.). On growth, Serve Robotics Inc. posted the faster year-over-year revenue change (400.1% vs -95.1%). Over the past eight quarters, Serve Robotics Inc.'s revenue compounded faster (-3.5% CAGR vs -75.9%).
Atara Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing allogeneic T-cell immunotherapies for patients with unmet medical needs across oncology, autoimmune disease, and infectious disease indications. It operates primarily in North America, Europe, and Asia-Pacific, partnering with research institutions to advance its novel treatment pipeline.
Ecovacs Robotics is a Chinese technology company. It is best known for developing in-home robotic appliances. The company was founded in 1998 by Qian Dongqi and is headquartered in Suzhou, China. According to Global Asia, Ecovacs Robotics had more than 60% of the Chinese market for robots by 2013. In 2023, Nikkei Asia had reported that the market capitalisation of Ecovacs Robotics has grown to near $6.38 billion, which is "roughly 5 times" that of the market capitalisation of rivalling US bas...
ATRA vs SERV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.6M | $881.5K |
| Net Profit | — | $-34.3M |
| Gross Margin | — | -757.3% |
| Operating Margin | — | -4572.1% |
| Net Margin | — | -3888.1% |
| Revenue YoY | -95.1% | 400.1% |
| Net Profit YoY | 73.2% | -161.3% |
| EPS (diluted) | — | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.6M | $881.5K | ||
| Q3 25 | $3.5M | $687.0K | ||
| Q2 25 | $17.6M | $642.0K | ||
| Q1 25 | $98.1M | $440.5K | ||
| Q4 24 | $32.8M | $176.3K | ||
| Q3 24 | $40.2M | $222.0K | ||
| Q2 24 | $28.6M | $468.0K | ||
| Q1 24 | $27.4M | $946.7K |
| Q4 25 | — | $-34.3M | ||
| Q3 25 | $-4.3M | $-33.0M | ||
| Q2 25 | $2.4M | $-20.9M | ||
| Q1 25 | $38.0M | $-13.2M | ||
| Q4 24 | $-12.7M | $-13.1M | ||
| Q3 24 | $-21.9M | $-8.0M | ||
| Q2 24 | $-19.0M | $-9.0M | ||
| Q1 24 | $-31.8M | $-9.0M |
| Q4 25 | — | -757.3% | ||
| Q3 25 | — | -637.4% | ||
| Q2 25 | — | -445.3% | ||
| Q1 25 | — | -333.4% | ||
| Q4 24 | — | -371.7% | ||
| Q3 24 | — | -70.3% | ||
| Q2 24 | — | 30.3% | ||
| Q1 24 | — | 62.8% |
| Q4 25 | — | -4572.1% | ||
| Q3 25 | -103.5% | -5067.8% | ||
| Q2 25 | 18.2% | -3527.1% | ||
| Q1 25 | 39.5% | -3406.6% | ||
| Q4 24 | -37.3% | -7701.3% | ||
| Q3 24 | -54.1% | -3804.1% | ||
| Q2 24 | -63.7% | -1828.2% | ||
| Q1 24 | -114.2% | -814.6% |
| Q4 25 | — | -3888.1% | ||
| Q3 25 | -124.6% | -4806.4% | ||
| Q2 25 | 13.6% | -3247.7% | ||
| Q1 25 | 38.7% | -3000.5% | ||
| Q4 24 | -38.8% | -7441.8% | ||
| Q3 24 | -54.5% | -3601.8% | ||
| Q2 24 | -66.5% | -1931.2% | ||
| Q1 24 | -116.1% | -954.7% |
| Q4 25 | — | $-0.50 | ||
| Q3 25 | $-0.32 | $-0.54 | ||
| Q2 25 | $0.19 | $-0.36 | ||
| Q1 25 | $3.50 | $-0.23 | ||
| Q4 24 | $0.27 | $-0.23 | ||
| Q3 24 | $-2.93 | $-0.20 | ||
| Q2 24 | $-3.10 | $-0.27 | ||
| Q1 24 | $-5.65 | $-0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.5M | $106.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-38.5M | $350.7M |
| Total Assets | $20.2M | $367.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.5M | $106.2M | ||
| Q3 25 | $13.7M | $116.8M | ||
| Q2 25 | $22.3M | $116.7M | ||
| Q1 25 | $13.8M | $197.8M | ||
| Q4 24 | $42.5M | $123.3M | ||
| Q3 24 | $67.2M | $50.9M | ||
| Q2 24 | $35.3M | $28.8M | ||
| Q1 24 | $46.2M | — |
| Q4 25 | $-38.5M | $350.7M | ||
| Q3 25 | $-36.6M | $283.9M | ||
| Q2 25 | $-35.0M | $207.2M | ||
| Q1 25 | $-55.1M | $210.2M | ||
| Q4 24 | $-97.3M | $131.7M | ||
| Q3 24 | $-90.5M | $56.2M | ||
| Q2 24 | $-110.9M | $28.5M | ||
| Q1 24 | $-98.3M | $-8.8M |
| Q4 25 | $20.2M | $367.8M | ||
| Q3 25 | $30.2M | $299.1M | ||
| Q2 25 | $36.9M | $214.3M | ||
| Q1 25 | $62.0M | $216.6M | ||
| Q4 24 | $109.1M | $139.6M | ||
| Q3 24 | $142.7M | $61.5M | ||
| Q2 24 | $117.3M | $32.8M | ||
| Q1 24 | $165.3M | $4.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-50.9M | $-29.6M |
| Free Cash FlowOCF − Capex | — | $-46.1M |
| FCF MarginFCF / Revenue | — | -5234.4% |
| Capex IntensityCapex / Revenue | 0.0% | 1872.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-117.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-50.9M | $-29.6M | ||
| Q3 25 | $-9.8M | $-25.2M | ||
| Q2 25 | $-7.3M | $-16.0M | ||
| Q1 25 | $-28.1M | $-9.5M | ||
| Q4 24 | $-24.5M | $-6.3M | ||
| Q3 24 | $-4.0M | $-5.5M | ||
| Q2 24 | $-10.6M | $-5.7M | ||
| Q1 24 | $-29.6M | $-4.1M |
| Q4 25 | — | $-46.1M | ||
| Q3 25 | — | $-36.5M | ||
| Q2 25 | — | $-22.0M | ||
| Q1 25 | — | $-12.9M | ||
| Q4 24 | $-24.6M | $-11.1M | ||
| Q3 24 | — | $-10.1M | ||
| Q2 24 | $-10.7M | $-6.5M | ||
| Q1 24 | $-29.7M | $-4.1M |
| Q4 25 | — | -5234.4% | ||
| Q3 25 | — | -5314.1% | ||
| Q2 25 | — | -3426.8% | ||
| Q1 25 | — | -2934.1% | ||
| Q4 24 | -75.0% | -6307.8% | ||
| Q3 24 | — | -4529.7% | ||
| Q2 24 | -37.3% | -1396.6% | ||
| Q1 24 | -108.7% | -431.1% |
| Q4 25 | 0.0% | 1872.1% | ||
| Q3 25 | 0.0% | 1649.6% | ||
| Q2 25 | 0.0% | 940.4% | ||
| Q1 25 | 0.0% | 785.7% | ||
| Q4 24 | 0.3% | 2755.1% | ||
| Q3 24 | 0.0% | 2070.7% | ||
| Q2 24 | 0.1% | 169.8% | ||
| Q1 24 | 0.5% | 0.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -3.07× | — | ||
| Q1 25 | -0.74× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
